NLRX1 and myeloid sarcoma: In MS, NLRX1 (NLR family member X1) exhibits context-dependent effects, exacerbating inflammasome activation in MS’s autoimmune milieu by amplifying type I interferon responses, while mitigating ROS-mediated damage in ALS by regulating mitochondrial quality control [58,59].